Diagnostic Value of Serum Biomarkers for Invasive Aspergillosis in Haematologic Patients
Authors:
- Isabel MontesinosIMIsabel Montesinos
- Imane Saad AlbichrIAImane Saad Albichr
- Elodie CollingeECElodie Collinge
- Bénédicte DelaereBDBénédicte Delaere
- Te-Din HuangTHTe-Din Huang
- Pierre BogaertsPBPierre Bogaerts
- Corentin DeckersCDCorentin Deckers
- Mai HamoudaMHMai Hamouda
- Patrick M. HonoréPatrick M. Honoré
- Pierre BulpaPBPierre Bulpa
- Anne SonetASAnne Sonet
Open Access
- 20 September 2024
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (9) , 661
Abstract
Background: Invasive aspergillosis (IA) is a significant cause of morbidity and mortality in patients with haematological malignancies. Accurate diagnosis of IA is challenging due to non-specific symptoms and the impact of antifungal prophylaxis on biomarker sensitivity. Methods: This retrospective study evaluated the diagnostic performance of three serum biomarkers: Aspergillus Galactomannan Ag VirClia Monotest® (VirClia), Wako β-D-Glucan Test® (Wako BDG), and MycoGENIE Real-Time PCR® (MycoGENIE PCR). True positives were defined as patients with proven or probable IA (n = 14), with a positive Platelia Aspergillus Antigen® (Platelia) serving as a mycological criterion. True negatives were identified as patients with a positive Platelia assay but classified as non-probable IA (n = 10) and outpatients who consistently tested negative with the Platelia test throughout the study period (n = 20). Results: Most patients diagnosed with proven or probable IA were acute myeloid leukaemia or myelodysplastic syndrome patients receiving mould-active antifungal prophylaxis or treatment (71%). VirClia demonstrated high sensitivity (100%) for detecting IA, with a specificity of 83%. Wako BDG and MycoGENIE PCR showed lower sensitivities for IA (57% and 64%, respectively). MycoGENIE PCR detected Aspergillus spp. and Mucorales in two patients. Conclusions: Accurate diagnosis of IA remains challenging, especially in patients who have received mould-active antifungal treatment. VirClia showed comparable performance to Platelia, suggesting its potential for routine use. However, Wako BDG and MycoGENIE PCR results were less favourable in our study cohort. Nevertheless, MycoGENIE PCR detected two probable co-infections with Aspergillus spp. and Mucorales.Keywords
Funding Information
- Fondation Mont-Godinne (FMG-BR-2023-008)
This publication has 28 references indexed in Scilit:
- Polymerase Chain Reaction of Plasma and Bronchoalveolar Lavage Fluid for Diagnosing Invasive AspergillosisClinical Infectious Diseases, 2023
- Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective TrialClinical Infectious Diseases, 2022
- Serology anno 2021—fungal infections: from invasive to chronicClinical Microbiology and Infection, 2021
- Aspergillus Polymerase Chain Reaction—An Update on Technical Recommendations, Clinical Applications, and Justification for Inclusion in the Second Revision of the EORTC/MSGERC Definitions of Invasive Fungal DiseaseClinical Infectious Diseases, 2021
- An Approach to Suspected Invasive Fungal Infection in Patients with Hematologic Malignancy and HCT Recipients with Persistent Neutropenic Fever Despite Mold-Active ProphylaxisCurrent Fungal Infection Reports, 2020
- Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised peopleCochrane Database of Systematic Reviews, 2019
- AspergillusPolymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen TestingClinical Infectious Diseases, 2015
- Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold ProphylaxisClinical Infectious Diseases, 2014
- -D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysisClinical Infectious Diseases, 2011
- Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosisThe Lancet Infectious Diseases, 2004